CoChat

Olanzapine Versus Placebo in Acute Mania: Treatment Responses in Subgroups

Baldessarini, Ross J., Hennen, John, Wilson, Michael, Calabrese, Joseph, Chengappa, Roy, Keck, Paul E., McElroy, Susan L., Sachs, Gary, Vieta, Eduard, Welge, Jeffrey A., Yatham, Lakshmi N., Zarate, Carlos A., Baker, Robert W., Tohen, Mauricio · 2003 · Journal of Clinical Psychopharmacology
Cited by 61

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Two double-blind, placebo-controlled trials of olanzapine in acute mania showed significant overall antimanic efficacy, based on reductions in mania ratings. Their subject-level data were pooled to increase statistical power to test for differences in treatment responses among 10 subgroup pairs of interest using generalized estimating equations methods. Similar drug/placebo superiority and responsiveness to olanzapine was found in men versus women, psychotic versus nonpsychotic subjects, and those presenting in mania versus mixed states, and responses were independent of onset age, current age, or prior illness based on episodes, hospitalizations, recent rapid cycling, lifetime substance use, or previous antipsychotic treatment. Olanzapine and placebo responses paralleled closely (r(s) = 0.73). Patients were relatively more responsive to olanzapine who were younger at illness onset, lacked prior substance abuse, and had not previously received antipsychotic treatment (efficacy ratios 1.5-1.7, all P < 0.01). These well-powered comparisons of subgroups of interest indicate broad efficacy of olanzapine in the treatment of acute mania.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/01.jcp.0000085410.08426.9a

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 61

Metadata

Authors
Baldessarini, R. J., Hennen, J., Wilson, M., Calabrese, J., Chengappa, R., Keck, P. E., McElroy, S. L., Sachs, G., Vieta, E., Welge, J. A., Yatham, L. N., Zarate, C. A., Baker, R. W., & Tohen, M.
Venue
Journal of Clinical Psychopharmacology
Published
2003-08
Volume
23
Issue
4
Pages
370-376
ISSN
0271-0749 (ISSN-L)
OpenAlex
W2030841280
Cited by
61
References
2
FWCI
3.89
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Olanzapine Versus Placebo in Acute Mania: Treatment Responses in Subgroups. https://app.cochat.ai/papers/10.1097/01.jcp.0000085410.08426.9a
The paper
Baldessarini, R. J., Hennen, J., Wilson, M., Calabrese, J., Chengappa, R., Keck, P. E., McElroy, S. L., Sachs, G., Vieta, E., Welge, J. A., Yatham, L. N., Zarate, C. A., Baker, R. W., & Tohen, M. (2003). Olanzapine Versus Placebo in Acute Mania: Treatment Responses in Subgroups. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/01.jcp.0000085410.08426.9a

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.